Caerus Pharma

Active Risk: not assessed

Limited partnershipfounded 2026active for less than a yearPastuurdijk 15, 8301 Knokke-Heist, BelgiumKBO/BCE: BE 1035.787.378

Summary

Caerus Pharma is less than twelve months old; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank.

Risk analysisFollow Report Compare

Caerus PharmaActive

Risk analysis Report Compare

History

Caerus Pharma was incorporated on 20 March 2026 as a limited partnership by one natural person.¹² Since 2026, STEPHAN BRACKENIER has served as manager of the company.²

Acts, filings and financial milestones

All 1Gazette 1

2026

24-03

Gazette deed Incorporation

Appointment: STEPHAN BRACKENIER (manager) · Partner · Founder10 facts ▸

Incorporation, Caerus Pharma
Partner, STEPHAN BRACKENIER (general partner)
Founder, STEPHAN BRACKENIER (general partner)
Founding capital
Other provision, “verslaggeving en revisorale controle bij inbreng in natura of nijverheid, onbeperkte aansprakelijkheid gecommanditeerde vennoten” (deed in Dutch)
Other provision, “statutaire zaakvoerders bij oprichting” (deed in Dutch)
Director appointment, STEPHAN BRACKENIER (manager (not named in the articles))
Pre-incorporation commitments, ratification, “alle verbintenissen aangegaan in naam en voor rekening van vennootschap in oprichting, met overname van verbintenissen, verplichtingen en rechten” (deed in Dutch)
Other provision, “neerlegging, Lasthebber” (deed in Dutch)
Director in office, STEPHAN BRACKENIER (manager)

Gazette deed

1 of 1 deed read